| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accessing health care autistically: a routine nasojejunal tube replacement
|
Larrington-Spencer, Harrie
|
|
|
8 |
9 |
p. 787-788
|
article
|
| 2 |
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
|
Dajti, Elton
|
|
|
8 |
9 |
p. 816-828
|
article
|
| 3 |
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
|
Kliewer, Kara L
|
|
|
8 |
9 |
p. 803-815
|
article
|
| 4 |
Britta Siegmund: answering the big questions in IBD
|
Kirby, Tony
|
|
|
8 |
9 |
p. 786
|
article
|
| 5 |
Clinical application of circulating tumour DNA in colorectal cancer
|
Loft, Matthew
|
|
|
8 |
9 |
p. 837-852
|
article
|
| 6 |
Correction to Lancet Gastroenterol Hepatol 2023; published online July 4. https://doi.org/10.1016/S2468-1253(23)00157-7
|
|
|
|
8 |
9 |
p. e7
|
article
|
| 7 |
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
|
Parigi, Tommaso Lorenzo
|
|
|
8 |
9 |
p. 853-859
|
article
|
| 8 |
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
|
Yuen, Man-Fung
|
|
|
8 |
9 |
p. 790-802
|
article
|
| 9 |
Is it time for a paradigm shift in treatment guidelines for chronic hepatitis B?
|
Johannessen, Asgeir
|
|
|
8 |
9 |
p. 784
|
article
|
| 10 |
More is not always better for novel hepatitis B therapies
|
Lens, Sabela
|
|
|
8 |
9 |
p. 772-773
|
article
|
| 11 |
NAFLD and liver-related events: does type 2 diabetes have a key role?
|
Vilar-Gomez, Eduardo
|
|
|
8 |
9 |
p. 777-778
|
article
|
| 12 |
Poor disease knowledge among people living with hepatitis B in The Gambia and Tanzania
|
Vo-Quang, Erwan
|
|
|
8 |
9 |
p. 783-784
|
article
|
| 13 |
Poor Little Sick Girls: A Love Letter to Unacceptable Women
|
Islam, Tanzina
|
|
|
8 |
9 |
p. 788-789
|
article
|
| 14 |
Rare cause of dysphagia in a young woman
|
Alwali, Ahmed
|
|
|
8 |
9 |
p. 860
|
article
|
| 15 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
9 |
p. 785
|
article
|
| 16 |
Spleen stiffness to identify clinically significant portal hypertension
|
Ripoll, Cristina
|
|
|
8 |
9 |
p. 775-776
|
article
|
| 17 |
Targeting type 2 immune responses to treat eosinophilic gastritis
|
Burns, Grace L
|
|
|
8 |
9 |
p. 773-775
|
article
|
| 18 |
The top 10 research priorities for pancreatitis: findings from a James Lind Alliance priority setting partnership
|
Mitra, Vikramjit
|
|
|
8 |
9 |
p. 780-782
|
article
|
| 19 |
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
|
Huang, Daniel Q
|
|
|
8 |
9 |
p. 829-836
|
article
|
| 20 |
Unsilencing liver disease
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
9 |
p. 771
|
article
|
| 21 |
Viral hepatitis in Asia-Pacific: a post-COVID-19 reset
|
Wallace, Jack
|
|
|
8 |
9 |
p. 778-780
|
article
|
Journal description